Nontuberculous mycobacteria in cystic fibrosis patients on the Island of Gran Canaria. A population study

Journal of Infection and Chemotherapy

Volumn 22, Issue 8, 2016, Pages 526-531

  Campos Herrero, Mª Isolina ^a   Chamizo, Francisco Javier ^a   Caminero, José Antonio ^a   Gilarranz, Raúl ^a   Cabrera, Gonzalo ^b   Cuyás, José ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Colonization; Cystic fibrosis; Disease, Mycobacterium abscessus complex; Mycobacterium simiae; Nontuberculous mycobacteria; Prevalence

Indexed keywords

ACID FAST BACTERIUM; ADULT; ARTICLE; ASPERGILLUS; ATYPICAL MYCOBACTERIUM; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CANARY ISLANDS; CHILD; COHORT ANALYSIS; CONCURRENT INFECTION; CYSTIC FIBROSIS; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM PEREGRINUM; MYCOBACTERIUM SIMIAE; NONHUMAN; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION; ADOLESCENT; ISOLATION AND PURIFICATION; LUNG; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NEWBORN; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LUNG; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PREVALENCE; YOUNG ADULT;

EID: 84973867736     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2016.04.010     Document Type: Article

References (25)

1. [1] Pedraza, G.F., San Jose, A.C., Cobos, B.N., Fernandez, P.F., Martin, C.N., [Isolation of mycobacteria in patients with cystic fibrosis: a prospective study]. An Esp Pediatr 45 (1996), 157–160.
2. [2] Oliver, A., Maiz, L., Canton, R., Escobar, H., Baquero, F., Gomez-Mampaso, E., Nontuberculous mycobacteria in patients with cystic fibrosis. Clin Infect Dis 32 (2001), 1298–1303, 10.1086/319987.
3. [3] Giron, R.M., Domingo, D., Buendia, B., Anton, E., Ruiz-Velasco, L.M., Ancochea, J., [Nontuberculous mycobacteria in patients with cystic fibrosis]. Arch Bronconeumol 41 (2005), 560–565, 10.1016/S1579-2129(06)60283-8.
4. [4] Giron, R.M., Maiz, L., Barrio, I., Martinez, M.T., Salcedo, A., Prados, C., Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study. Arch Bronconeumol 44 (2008), 679–684, 10.1016/S1579-2129(09)60006-9.
5. [5] Clinical and Laboratory Standards, Susceptibility testing for mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard-second edition. CLSI document M24–A2. 2011, Clinical and Laboratory Standards Institute, Wayne, PA.
6. [6] Griffith, D.E., Aksamit, T., Brown-Elliott, B.A., Catanzaro, A., Daley, C., Gordin, F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175 (2007), 367–416, 10.1164/rccm.200604-571ST.
7. [7] Olivier, K.N., Weber, D.J., Wallace, R.J., Faiz, A.R., Lee, J.H., Zhang, Y., et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 167 (2003), 828–834, 10.1164/rccm.200207-678OC.
8. [8] Esther, C.R. Jr., Esserman, D.A., Gilligan, P., Kerr, A., Noone, P.G., Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 9 (2010), 117–123, 10.1016/j.jcf.2009.12.001.
9. [9] Whittier, S., Hopfer, R.L., Knowles, M.R., Gilligan, P.H., Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 31 (1993), 861–864.
10. [10] Pierre-Audigier, C., Ferroni, A., Sermet-Gaudelus, I., Le Bourgeois, M., Offredo, C., Vu-Thien, H., et al. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 43 (2005), 3467–3470, 10.1128/JCM.43.7.3467-3470.2005.
11. [11] Seddon, P., Fidler, K., Raman, S., Wyatt, H., Ruiz, G., Elston, C., et al. Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom. Emerg Infect Dis 2013 19 (2009), 1128–1130, 10.3201/eid/1907.120615.
12. [12] Levy, I., Grisaru-Soen, G., Lerner-Geva, L., Kerem, E., Blau, H., Bentur, L., et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis 14 (2008), 378–384, 10.3201/eid1403.061405.
13. [13] Roux, A.L., Catherinot, E., Ripoll, F., Soismier, N., Macheras, E., Ravilly, S., et al. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France. J Clin Microbiol 47 (2009), 4124–4128, 10.1128/JCM.01257-09.
14. [14] Qvist, T., Giljam, M., Jonsson, B., Taylor-Robinson, D., Jensen-Fangel, S., Wang, M., et al. Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. J Cyst Fibros 14 (2015), 46–52, 10.1016/j.jcf.2014.08.002.
15. [15] Adjemian, J., Olivier, K.N., Prevots, D.R., Nontuberculous mycobacteria among patients with cystic fibrosis in the United States. Screening practices and environmental risk. Am J Respir Crit Care Med 190 (2014), 581–586, 10.1164/rccm.201405-0884OC.
16. [16] Bar-On, O., Mussaffi, H., Mei-Zahav, M., Prais, D., Steuer, G., Stafler, P., et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros 14 (2015), 53–62, 10.1016/j.jcf.2014.05.008.
17. [17] Martiniano, S.L., Nick, J.Á., Nontuberculous mycobacterial infections in cystic fibrosis. Clin Chest Med 36 (2015), 101–115, 10.1016/j.ccm.2014.11.003.
18. [18] Harris, K.A., Underwood, A., Kenna, D.T., Brooks, A., Kavaliunaite, E., Kapatai, G., et al. Whole-genome sequencing and epidemiological analysis do not provide evidence for cross-transmission of Mycobacterium abscessus in a cohort of pediatric cystic fibrosis patients. Clin Infect Dis 60 (2015), 1007–1016, 10.1093/cid/ciu967.
19. [19] Mussaffi, H., Rivlin, J., Shalit, I., Ephros, M., Blau, H., Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 25 (2005), 324–328, 10.1183/09031936.05.00058604.
20. [20] Leung, J.M., Olivier, K.N., Nontuberculous mycobacteria in patients with cystic fibrosis. Semin Respir Crit Care Med 34 (2013), 124–134, 10.1055/s-0033-1333574.
21. [21] Samra, Z., Kaufman, L., Pitlik, S., Shalit, I., Bishara, J., Emergence of Mycobacterium simiae in respiratory specimens. Scand J Infect Dis 37 (2005), 838–841, 10.1080/00365540500264712.
22. [22] Catherinot, E., Roux, A.L., Vibet, M.A., Bellis, G., Ravilly, S., Lemonnier, L., et al. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patients populations. J Cyst Fibros 12 (2013), 74–80, 10.1016/j.jcf.2012.06.00.
23. [23] Olivier, K.N., Weber, D.J., Lee, J.H., Handler, A., Tudor, G., Molina, P.L., et al. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med 167 (2003), 835–840, 10.1164/rccm.200207-679OC.
24. [24] Hayes, D. Jr., Mycobacterium abscessus and other nontuberculous mycobacteria: evolving respiratory pathogens in cystic fibrosis: a case report and review. South Med J 98 (2005), 657–661, 10.1097/01.SMJ.0000163311.70464.91.
25. [25] Razvi, S., Saiman, L., Nontuberculous mycobacteria in cystic fibrosis. Pediatr Infect Dis J 26 (2007), 263–264, 10.1097/01.inf.0000256964.30181.df.